VECATA
Vecata Invest A/S is an investment company managing the Bagger-Sorensen Group’s direct investments in operative companies. Vecata Invest A/S do not focus on specific industries. The investments are made direct in relevant portfolio companies and Vecata Invest A/S participates actively in the development of these. The company does not invest in the funds-of-funds segment.
VECATA
Founded:
2003-01-01
Status:
Active
Contact:
+45 7215 1500
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Domain Not Resolving Global Site Tag US Privacy User Signal Mechanism Google Analytics 4
Current Advisors List
Claus Bagger Board Member @ Vecata Board_member
Torben Vilsgaard Board Member @ Vecata Board_member
Torben Brogger Board Member @ Vecata Board_member
Erik G. Hansen Board Member @ Vecata Board_member
Current Employees Featured
Hans-Henrik Eriksen
Hans-Henrik Eriksen CEO @ Vecata CEO
John Riis Mortensen
John Riis Mortensen Investment Director @ Vecata Investment Director
Birgith Rask Jensen
Birgith Rask Jensen P.A. in Vecata @ Vecata P.A. in Vecata
Jennifer Fode
Jennifer Fode P.A. @ Vecata P.A.
Steen Bagger-Sorensen
Steen Bagger-Sorensen Investment Director @ Vecata Investment Director
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2017-12-01 | FlexFunding | Vecata investment in Pre Seed Round - FlexFunding | N/A |
2009-02-02 | Proxeon | Vecata investment in Venture Round - Proxeon | 2.41 M USD |
2008-07-23 | Fluxome | Vecata investment in Series B - Fluxome | 13 M EUR |
2007-12-19 | Zoomio Holding | Vecata investment in Venture Round - Zoomio Holding | 7.13 M USD |
2007-01-25 | Anapa Biotech | Vecata investment in Venture Round - Anapa Biotech | 1000 K USD |
2005-11-30 | Fluxome | Vecata investment in Venture Round - Fluxome | 7.2 M USD |
2005-03-01 | LiPlasome Pharma | Vecata investment in Series B - LiPlasome Pharma | 8.01 M USD |